Search
for
Sort by
Research 751–780 of 1000+
- A Systematic Review of Case Series and Clinical Trials Investigating Regenerative Medicine for the Treatment of Vitiligo
- Drug Armamentarium for alopecia areata
- Novel Quinazoline Derivative Induces Differentiation of Keratinocytes and Enhances Skin Barrier Functions against Th2 Cytokine-Mediated Signaling
- The influence of interferon on healthy and diseased skin
- Alopecia Areata and Dexamethasone Mini-Pulse Therapy, A Prospective Cohort: Real World Evidence and Factors Related to Successful Response
- Analysis of histology and long noncoding RNAs involved in the rabbit hair follicle density using RNA sequencing
- Long‐term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO‐LT phase 3, open‐label study
- Application of Baricitinib in Dermatology
- Evaluation of the level of serum Interleukins (IL-2, IL-4, IL-15 andIL-17) and its relationship with disease severity in patients with alopecia areata
- Patterns of clinical response in patients with alopecia areata treated with ritlecitinib in the ALLEGRO clinical development programme
- Baricitinib-loaded separable microneedle array patch (S-MAP) based on hyaluronic acid for alopecia areata therapy
- Bletilla striata polysaccharide-based dissolving microneedle patch integrated with nanoparticles for promoting hair regrowth
- Effective treatment of refractory alopecia areata in pediatric patients with oral abrocitinib
- Platelet-rich plasma in the treatment of alopecia areata: A retrospective evaluation of 17 patients
- Genomic and phenotypic characterization of Investigator Global Assessment (IGA) scale-based endotypes in atopic dermatitis
- Microneedling combined with compound betamethasone in treatment of severe alopecia areata: A case report
- Evaluating the Causal Relationship Between Human Blood Metabolites and the Susceptibility to Alopecia Areata
- Role of the SOX family in cancer immune evasion: Emerging player and promising therapeutic opportunities
- Rapid hair regrowth in an alopecia universalis patient with deucravacitinib: A case report
- Population exposure–response analysis of the effect of ritlecitinib on eyebrow assessment and eyelash assessment in patients with alopecia areata
- KRT6A derived from mesenchymal stem cells as a potential biomarker and therapeutic target for alopecia areata: insights from multi-omics analysis and experimental evidence
- Upadacitinib for the Management of Alopecia Totalis and Subtotalis in Pediatric Patients: A Case Series
- Association of JAK 1 and JAK 2 gene polymorphism with alopecia areata risk: a case–control genetic study
- Systemic Absorption and Pharmacokinetics of Five Novel Topical Dermatologic Agents: A Review
- Optimization of photobiomodulation therapy for spinal cord injury: A review
- Epidermal γδ T cells, CD8 T cells and macrophages are increased in number in alopecia areata and express BST2 as part of an interferon-driven antiviral gene signature
- Reconsidering the classification of vitiligo and alopecia as cosmetic concerns in Medicaid and Tricare policies
- Efficacy, safety and tolerability of drugs for alopecia: a comprehensive review
- Predictive factors for treatment responses to baricitinib in severe alopecia areata: A retrospective, multivariate analysis of 70 cases from a single center
- Efficacy and Safety of Baricitinib in Patients With Alopecia Areata: A Real‐World Cohort Study